Covid-19: Bharat Biotech begins Phase 3 trials of Covaxin in India

The trial will be conducted in partnership with the Indian Council of Medical Research (ICMR), the Hyderabad-based drugmaker said in a statement.

Posted from: this blog via Microsoft Flow.